2023-2024 Updated Vaccine
Now Available in the U.S.

Information about our vaccine for Healthcare Professionals

Please visit our authorization website for healthcare professionals for information on vial expiration dates, efficacy, safety, and other resources.

Go to expiry checker & other resources

Latest press release on vaccine candidates

View press releases

COVID-19 vaccine research updates

Novavax COVID-19 vaccine (recombinant, adjuvanted) is now conditionally authorized in several regions

Latest update

Novavax information for:

NEWS & MEDIA

Novavax Announces Launch of Choose to Protect Campaign

Full press release

NEWS & MEDIA

Current Protocol for Phase 3 Clinical Trial of NVX-CoV2373 in the U.S. and Mexico

Full press release

Novavax's Investor Hub

Visit our Investor Hub to access investor resources and information on upcoming and past events. Sign up to receive notifications for investor updates, such as upcoming events and webcasts, daily closing stock price, SEC filings, and press releases.